Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunity in hepatitis C infection.

A M Prince1, B Brotman, T Huima

  • 1Laboratory of Virology and Parasitology, Lindsley F. Kimball Research Institute of New York Blood Center, New York.

The Journal of Infectious Diseases
|March 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PM289, a synthetic CB2 in vitro receptor agonist, modulates morphine-induced antinociceptive effect and withdrawal syndrome in an animal model of osteoarthritic pain.

Neuropharmacology·2026
Same author

Chronic pain and cannabinoids. Great expectations or a christmas carol.

Biochemical pharmacology·2018
Same author

Recognition of Core- and Polymerase-derived immunogenic peptides included in novel therapeutic vaccine by T cells from Chinese chronic hepatitis B patients.

Journal of viral hepatitis·2017
Same author

T- and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates.

Gene therapy·2016
Same author

[Guided and computer-assisted implant surgery and prosthetic: The continuous digital workflow].

Revue de stomatologie, de chirurgie maxillo-faciale et de chirurgie orale·2016
Same author

Cancer Incidence in Heart Transplant Recipients With Previous Neoplasia History.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015

Hepatitis C virus (HCV) reinfection in chimpanzees suggests weak immunity. Most animals showed signs of reinfection, but responses were reduced after secondary exposure, indicating limited protection.

Area of Science:

  • Virology
  • Immunology
  • Hepatology

Background:

  • Hepatitis C virus (HCV) poses a significant global health challenge.
  • Understanding immune responses to HCV is crucial for vaccine development and treatment strategies.

Observation:

  • This study investigated HCV cross-challenge episodes in 19 chimpanzees using polymerase chain reaction (PCR) and serologic assays.
  • Chimpanzees were challenged with homologous or heterologous HCV strains to assess reinfection dynamics.

Findings:

  • A total of 74% of chimpanzees showed at least one sign of reinfection, including seroconversion, reappearance of ultrastructural changes, or viral RNA detection.
  • However, the frequency of serologic and ultrastructural responses was significantly reduced in secondary infections compared to primary infections (P < .01).

Related Experiment Videos

  • No significant difference in response was observed between homologous and heterologous HCV strain challenges.

    • Implications:

    • The findings suggest that natural HCV infection induces relatively weak and potentially short-lived immunity.
    • This limited protective immunity has implications for the design of effective HCV vaccines and therapeutic strategies.
    • Further research is needed to elucidate the mechanisms underlying this weak immune response in HCV infection.